Agreed, I am sure the BOD is considering all options. My thought was because the SP is at $.50, it is unlikely for a company to offer $3B+ for buyout (~$5/share fully diluted). That would represent a 1000% premium. If/as the share price appreciates without BP (potential positive cancer results), then this become more likely IMO.
I’m sure I would not be the only one disappointed if a $3B BO was accepted tomorrow. I believe the potential for CYDY is much higher and other than the time value of money, landing a solid BP deal would be the better long term play.
News 
Market Data 
Discover 
